Is rocuronium an exception to the relation between onset and offset? A comparison with pipecuronium

European Journal of Anaesthesiology

Volumn 13, Issue 4, 1996, Pages 385-388

  England, A J ^a   Panikkar, K ^b   Redai, I ^b   Haxby, E ^b   Gopinath, S ^b   Feldman, S A ^b  

^a EAST SURREY HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Neuromuscular blockade, onset time, offset time; Neuromuscular blocking drugs, pipecuronium, rocuronium

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; PIPECURONIUM; ROCURONIUM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; FOREARM; HUMAN; HUMAN EXPERIMENT; NEUROMUSCULAR BLOCKING; NORMAL HUMAN; SYNAPTIC TRANSMISSION;

EID: 0030035338     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199607000-00015     Document Type: Article

References (15)

1. Armstrong DL, Lester HA. The kinetics of tubocurarine action and restricted diffusion within the synaptic cleft. J Physiol 1979; 294: 365-386.
2. Feldman SA, Wu X, England AJ. Rate of onset and offset of four non depolarizing neuromuscular blocking agents. Anaesthesia 1995; 50: 510-513.
3. Booth MG, Marsh B, Bryden FM, Robertson EN, Baird WL. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992; 47: 832-834.
4. Waser PG. Die Pharma kologie der calabassenalkaloide in Curare. In: Waser PG, ed. Symposium. Basel: Schwabe and Co., 1966: 486-500.
5. Campkin NTA, Hood JR. The isolated arm. Anaes Pharmacol Rev 1993; 1: 77-80.
6. Goat V, Yeung ML, Blakeney C, Feldman SA. Effect of blood flow upon the activity of gallamine triethiodide. Br J Anaesth 1976; 48: 69-72.
7. White DA, Reita JH. Effect of blood flow in pharmacodynamics of non depolarising muscle relaxants using an isolated limb model. Anesthesiology 1984; 41: A286.
8. Stenlake JB, Hughes R. In vitro degradation of atracurium in human plasma. Br J Anaesth 1987; 59: 805-807.
9. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuro-muscular pharmacology of mivacurium chloride (BW B1090U). A short acting non depolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
10. Feldman SA, Tyrell MF. A new theory of the termination of action of the muscle relaxants. Proc R Soc Med 1970; 63: 692-695.
11. Feldman S. Biophase binding: its effect on recovery from non-depolarising neuromuscular block. Anaes Pharmacol Rev 1993; 1: 81-87.
12. Bowman WC. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 1980; 59: 935-943.
13. Feldman S, Hood J. Depolarizing neuromuscular block - a presynaptic mechanism? Acta Anaesthesiol Scand 1994; 38: 535-541.
14. Lambalk LM, De Wit APM, Wierda JMKH, Hennis PJ, Agoston S. Dose-response relationship and time course of action of Org 9426. Anaesthesia 1991; 46: 907-911.
15. Feldman SA, Khaw K. The effect of dose on the action of rocuronium and on the effect of the rate of stimulation. Eur J Anaesthesiol 1995; 12: 15-17.